001060 — JW Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩693bn
- KR₩812bn
- KR₩749bn
- 96
- 58
- 81
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -25,275 | -15,275 | -1,441 | 29,853 | 38,430 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 14,346 | 28,243 | 56,357 | 51,780 | 64,300 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 46,523 | 29,399 | -52,903 | -41,704 | -38,147 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 55,531 | 63,054 | 18,124 | 56,764 | 87,157 |
Capital Expenditures | -13,096 | -15,039 | -12,902 | -12,353 | -40,705 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -8,887 | -64,388 | -9,968 | -6,567 | -23,075 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -21,984 | -79,427 | -22,869 | -18,919 | -63,780 |
Financing Cash Flow Items | — | — | — | — | -54 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -24,160 | -14,009 | 27,202 | -36,907 | -41,245 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 10,916 | -31,413 | 22,915 | 531 | -17,989 |